Abstract: String matching is time-consuming in data search applications, especially with extensive data and many users. This paper demonstrates the performance of hardware acceleration by showcasing ...

The original version of this story appeared in Quanta Magazine. If you want to solve a tricky problem, it often helps to get organized. You might, for example, break the problem into pieces and tackle ...

Jessica Alba is celebrating Hispanic Heritage Month by paying tribute to her fellow Latinas. In an Instagram carousel, she posed in a black button-up and peekaboo bra with the likes of Eva Longoria, ...

iShares Core 80/20 Aggressive Allocation ETF offers a low-cost, diversified 80/20 equity-to-bond allocation for long-term passive investors. AOA's portfolio is heavily weighted toward US equities, ...

Thousands marched in London to protest President Donald Trump’s second state visit. Among them were many environmental activists unhappy with Britain’s new AI deal with the US. They banged drums. They ...

Quantum researchers have deployed a new algorithm to manage noise in qubits in real time. The method can be applied to a wide range of different qubits, even in large numbers. Noise is the "ghost in ...

DETROIT — Aldrich Potgieter took a peek at the leaderboard before lining up his last putt on a crest of the ninth green, knowing he had to make the 12-footer for birdie to break a tie with Kevin Roy .

When gray-haired white liberals take to America’s streets for “No Kings” protests, the only danger they’re exposing themselves to is ridicule. What happens, though, when progressive protesters head to ...

The phase 3 VERONA trial did not meet the primary endpoint of overall survival. Topline data were announced from a phase 3 trial evaluating venetoclax (Venclexta ®) plus azacitidine for patients with ...

Serious infections in patients with CLL/SLL treated with combination venetoclax and obinutuzumab compared with those treated with zanubrutinib: A real-world study. This is an ASCO Meeting Abstract ...

Effectiveness and safety of the amivantamab to lazertinib versus lazertinib alone in EGFR mutant metastatic non-small-cell lung cancer: Systematic review and meta-analysis. Exploring the prognostic ...